Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium
David C Muller, Tricia L Larose, Allison Hodge, Florence Guida, Arnulf Langhammer, Kjell Grankvist, Klaus Meyer, Qiuyin Cai, Alan A Arslan, Anne Zeleniuch-Jacquotte, Demetrius Albanes, Graham G Giles, Howard D Sesso, I-Min Lee, J Michael Gaziano, Jian-Min Yuan, Judith Hoffman Bolton, Julie E Buring, Kala Visvanathan, Loic Le Marchand Show all
BMJ | BMJ PUBLISHING GROUP | Published : 2019
Awarded by National Institutes of Health/National Cancer Institute
Awarded by National Health and Medical Research Council
Awarded by Research Council of Norway
The Lung Cancer Cohort Consortium was supported by Grant National Institutes of Health/National Cancer Institute (no 1U01CA155340-01) and The National Health and Medical Research Council (Grant ID: 1050198). DCM receives funding from a Cancer Research UK Population Research Fellowship. This work was supported by The Research Council of Norway (grant no 267776/H10). The work undertaken by TLL for this paper was conducted during a postdoctoral placement at the International Agency for Research on Cancer, within the framework of an agreement between the Research Council of Norway and the Norwegian University of Science and Technology. The funding organisations had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript.